The conference will explore how digital is impacting – and disrupting – pharma, from the perspective of both the digital customer/consumer and the digitalisation of the product.
For the industry it is important to identify potential solutions to real patient challenges rather than starting with the technology and trying to find a use for it. Up for discussion will be harvesting ecosystem innovation through AI, ML, VR, IoT and blockchain; commercialisation of digital health in pharma; adoption of medical devices and exploration of digital therapeutics; assessing agile methodologies for a strategic digital transformation and boosting collaboration for enhanced service design and delivery
Delegate registration: GBP 1499.0
Speakers: Mark Campbell, Freelance Regulatory Expert, former NICE, Vladimir Anisimov, Principal Data Scientist, Amgen, Joseph Dalton, Global Lead Digital Health Solutions and Medical Outcomes, Novartis